Biosergen AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-38.01	-19.2	-27.04	-34.05	-36.39
Change in Receivables	-2.05	2.91	-0.87	3.37	-6.89
Changes in Accounts Payable	3.25	6.11	-5.11	0.06	-4.79
Changes in Other Operating Activities	-	-	0.42	1.17	1.33
Operating Cash Flow	-36.81	-10.18	-32.6	-29.44	-37.75
Operating Cash Flow Growth	-	-	-	-	-
Issuance of Common Stock	-	58.91	5.14	37.12	58.83
Net Common Stock Issued (Repurchased)	-	58.91	5.14	37.12	58.83
Other Financing Activities	-0.04	-	-	-	-
Financing Cash Flow	-0.04	58.91	5.14	37.12	58.83
Foreign Exchange Rate Adjustments	1.6	-	-	-	0
Net Cash Flow	-36.85	48.73	-27.46	7.68	21.08
Free Cash Flow	-36.81	-10.18	-32.6	-29.44	-37.75
Free Cash Flow Growth	-	-	-	-	-
FCF Margin	-	-524.64%	-347.65%	-568.03%	-440.32%
Free Cash Flow Per Share	-15.68	-4.33	-72.57	-94.37	-134.20
Levered Free Cash Flow	-34.76	-13.09	-31.73	-32.81	-37.78
Unlevered Free Cash Flow	-34.79	-13.09	-31.96	-32.9	-37.54